Last10K.com

Seagen Inc. (SGEN) SEC Filing 8-K Material Event for the period ending Tuesday, December 29, 2020

Seattle Genetics Inc Wa

HISTORY TOOLS
CIK: 1084961 Ticker: SGEN

View differences made from one to another to evaluate Seattle Genetics Inc Wa's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Seattle Genetics Inc Wa.

Continue

Assess how Seattle Genetics Inc Wa's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Seattle Genetics Inc Wa's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Document And Entity Information

Material Contracts, Statements, Certifications & more

Seattle Genetics Inc Wa provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: SGEN
CIK: 1060736
Form Type: 8-K Corporate News
Accession Number: 0001193125-20-328705
Submitted to the SEC: Tue Dec 29 2020 4:15:54 PM EST
Accepted by the SEC: Tue Dec 29 2020
Period: Tuesday, December 29, 2020
Industry: Biological Products No Disgnostic Substances
Events:
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/sgen/0001193125-20-328705.htm